Catalogo dei prodotti della ricerca

GIONA, Fiorina
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.688
EU - Europa 6.041
AS - Asia 2.423
SA - Sud America 112
AF - Africa 67
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 7
Totale 18.347
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.541
IT - Italia 3.400
SG - Singapore 1.193
SE - Svezia 891
IN - India 686
CN - Cina 428
FI - Finlandia 389
UA - Ucraina 328
DE - Germania 206
CA - Canada 130
GB - Regno Unito 129
RO - Romania 124
RU - Federazione Russa 108
IE - Irlanda 95
BG - Bulgaria 79
AR - Argentina 64
FR - Francia 60
NL - Olanda 42
TG - Togo 38
BR - Brasile 37
AT - Austria 35
BE - Belgio 32
CH - Svizzera 30
ID - Indonesia 23
ES - Italia 22
MX - Messico 16
AL - Albania 14
JP - Giappone 13
ZA - Sudafrica 13
HK - Hong Kong 11
TR - Turchia 11
AE - Emirati Arabi Uniti 10
LT - Lituania 10
IL - Israele 8
CL - Cile 7
EG - Egitto 7
TH - Thailandia 7
EU - Europa 6
IR - Iran 6
NZ - Nuova Zelanda 6
PL - Polonia 6
PT - Portogallo 6
TW - Taiwan 6
SA - Arabia Saudita 5
DK - Danimarca 4
EE - Estonia 4
GR - Grecia 4
KZ - Kazakistan 4
MA - Marocco 4
SM - San Marino 4
AU - Australia 3
CZ - Repubblica Ceca 3
LV - Lettonia 3
MY - Malesia 3
NO - Norvegia 3
SC - Seychelles 3
SK - Slovacchia (Repubblica Slovacca) 3
HR - Croazia 2
NG - Nigeria 2
PE - Perù 2
PH - Filippine 2
SI - Slovenia 2
A1 - Anonimo 1
BA - Bosnia-Erzegovina 1
BD - Bangladesh 1
BO - Bolivia 1
CO - Colombia 1
IM - Isola di Man 1
KG - Kirghizistan 1
KR - Corea 1
LK - Sri Lanka 1
MD - Moldavia 1
PA - Panama 1
PK - Pakistan 1
SY - Repubblica araba siriana 1
VN - Vietnam 1
Totale 18.347
Salva come PNG Salva come JPEG
Città #
Fairfield 1.048
Chandler 1.046
Singapore 871
Ashburn 706
Princeton 606
Rome 508
Woodbridge 487
Wilmington 407
Seattle 355
Houston 350
Plano 330
Cambridge 326
Des Moines 313
Santa Clara 294
Ann Arbor 287
Beijing 283
Boston 252
San Paolo di Civitate 182
Milan 155
Millbury 142
Lawrence 116
Andover 110
San Diego 104
Dearborn 97
Helsinki 96
Dublin 74
Jacksonville 73
Sofia 72
Toronto 66
Norwalk 63
Federal 62
Florence 59
New York 56
Ottawa 56
Naples 55
Bologna 51
Bremen 50
Moscow 44
Southend 42
Lomé 38
Boardman 36
Falkenstein 33
San Mateo 33
Bari 28
Turin 28
Vienna 28
Catania 27
Brussels 26
Genoa 26
Bühl 25
Los Angeles 22
Mannheim 22
Hefei 20
Palermo 20
Falls Church 19
Buffalo 18
Ferrara 17
Jakarta 17
Torino 17
Nanjing 15
Stockholm 15
Modena 13
Phoenix 13
Venice 13
Brescia 12
Napoli 12
Pisa 12
Genova 11
Laurel 11
San Marco in Lamis 11
Tokyo 11
Amsterdam 10
Bergamo 10
Hong Kong 10
Madrid 10
Ancona 9
Cagliari 9
Frankfurt am Main 9
Guangzhou 9
Kunming 9
Mexico City 9
Padova 9
Pistoia 9
Atella 8
Berlin 8
Bern 8
Carmarthen 8
Carnago 8
Istanbul 8
Perugia 8
Redmond 8
Reggio Emilia 8
Birkenhead 7
Cattolica 7
Dubai 7
Fasano 7
London 7
Lucca 7
Menlo Park 7
Nuremberg 7
Totale 11.183
Salva come PNG Salva come JPEG
Nome #
Terapia di salvataggio con il protocollo IEV seguito da chemioterapia ablativa e trapianto autologo in pazienti affetti da Hodgkin refrattari o in recidiva: risultati in 23 pazienti con età <18 anni alla diagnosi. 1.562
High dose cytarabine and idarubicin for the treatment of advanced acute lymphoblastic leukemia 281
Esperienza con l'imatinib ad intermittenza nei bambini e adolescenti con leucemia mieloide cronica (LMC): risultati e prospettive 226
Piastrinopenia immune HIV correlata: descrizione di 20 casi. 170
Mitoxantrone, Etoposide e dosi intermedie di ARA-C (protocollo MEC) nel trattamento della leucemia acuta mieloide (LAM) del bambino refrattario o in recidiva 168
Terapia con Idrossiurea in bambini e adolescenti affetti da anemia falciforme nel “real life setting 157
LOCALIZZAZIONE EXTRAMIDOLLARE DI LAM IN ETÀ PEDIATRICA: IL RUOLO DI UNA CORRETTA E TEMPESTIVA DIAGNOSI 139
Childhood polycythemia vera and essential thrombocythemia: Does their pathogenesis overlap with that of adult patients? 119
The revised WHO diagnostic criteria for Ph-negative myeloproliferative diseases are not appropriate for the diagnostic screening of childhood polycythemia vera and essential thrombocythemia 114
Le malattie rare 114
Markers of myeloproliferative diseases in childhood polycythemia vera and essential thrombocythemia. 113
Treatment-free remission after imatinib discontinuation is possible in paediatric patients with chronic myeloid leukaemia. 109
GIMEMA-AIEOP AIDA protocol for the treatment of newly diagnosed acute promyelocytic leukemia (APL) in children. 103
Epigenetic alteration of SOCS family members is a possible pathogenetic mechanism in JAK2 wild type myeloproliferative diseases 101
A case of motor neuron involvement in Gaucher disease 101
Malattia di Erdheim-Chester 99
99mTc-sestamibi scintigraphy to monitor the long-term efficacy of enzyme replacement therapy on bone marrow infiltration in patients with gaucher disease 98
A novel heterozygous HIF2AM535I mutation reinforces the role of oxygen sensing pathway disturbances in the pathogenesis of familial erythrocytosis. 96
BAVC regimen and autograft for acute myelogenous leukemia in second complete remission 95
Indomethacin is an effective treatment in adults and children with bone Langerhans cell histiocytosis (LCH) 95
Atypical chronic myeloid leukemia in a patient with aplastic anemia 92
Hereditary thrombocytosis caused by MPLSer505Asn is associated with a high thrombotic risk, splenomegaly and progression to bone marrow fibrosis. 91
A longitudinal electroencephalographic study in acute leukaemia. 90
Platelet activation and multidrug resistance protein-4 expression in children and adolescents with different subtypes of primary thrombocythemia 90
Early response does not predict outcome in children and adolescents with chronic myeloid leukaemia treated with high-dose imatinib 89
Leucemia acuta promielocitica del bambino: risultati del protocollo nazionale AIDA (LAP 0493) 89
CALR mutations in patients with essential thrombocythemia diagnosed in childhood and adolescence. 87
Thrombocythemia and polycythemia in patients younger than 20 years at diagnosis: clinical and biologic features, treatment, and long-term outcome 87
EFFICACIA DEL PEG-IFNΑ-2A IN UN CASO DI POLICITEMIA VERA PEDIATRICA 86
Real-Life Management of Children and Adolescents with Chronic Myeloid Leukemia: The Italian Experience 84
Long-term results of high-dose imatinib in children and adolescents with chronic myeloid leukaemia in chronic phase: the Italian experience. 84
Bone Metabolism and Endocrine Function in Children with Chronic Myeloid Leukemia (CML) Treated with Imatinib during Puberty. 83
Thrombopoietin Receptor Activation, Thrombopoietin Mimetic Drugs, and Hereditary Thrombocytosis: Remarks on Bone Marrow Fibrosis. 81
Mast cell leukemia: a report of ten cases. 80
Analysis of the glucocerebrosidase gene and mutation profile in 144 Italian gaucher patients. 80
INDOMETHACIN AS FIRST LINE TREATMENT OF LANGERHANS CELL HISTIOCYTOSIS (LCH). A 20-YEAR EXPERIENCE OF A SINGLE CENTRE. 79
CODOX-M/IVAC (NCI 89-C-41) for children and adolescents with small non-cleaved and large B-cell lymphomas. A 14 years monocentric experience 77
Standardization of MRI and Scintigraphic Scores for Assessing the Severity of Bone Marrow Involvement in Adult Patients with Type 1 Gaucher Disease. 77
Can chronic myeloid leukaemia in children and adolescents be successfully treated without haematopoietic stem cell transplant? A single centre experience 77
Gaucher Disease and Myelofibrosis: A Combined Disease or a Misdiagnosis? 77
Advanced mast cell disease: an Italian Hematological Multicenter experience 77
CODOX-M/IVAC (NCI 89-C-41) in children and adolescents with Burkitt's leukemia/lymphoma and large B-cell lymphomas: A 15-year monocentric experience. 76
Multidisciplinary study based on clinical, electrophysiological and psychological evaluation combined with advanced neuro imaging in Gaucher disease patients 75
EHA2021 Virtual Congress Abstract Book 75
Trombocitosi ereditaria: caratteristiche e andamento clinico in 4 famiglie osservate in un centro di Ematologia pediatrica. [Hereditary thrombocytosis: characterization and clinical trends in 4 families observed in a pediatric hematology center] 74
Long-term efficacy and safety results of taliglucerase alfa through 5years in adult treatment-naïve patients with Gaucher disease 73
The different dermoscopic features of the yellow background in Langerhans and non-Langerhans cells histiocytosis 73
Thrombopoietin receptor agonist use,efficacy and toxicity in children with immune thrombocytopenia: data from an Italian multicenter survey 73
A single high dose of idarubicin combined with high-dose ARA-C for treatment of first relapse in childhood 'high-risk' acute lymphoblastic leukaemia: a study of the AIEOP group. 73
Gamma-delta hepatosplenic T-cell lymphoma. Description of a case with immunophenotypic and molecular follow-up succesfully treated with chemotherapy alone 72
Twenty years of the Italian Fanconi Anemia Registry: Where we stand and what remains to be learned 72
UTILIZZO DELL’ELTROMBOPAG NELLA “REAL LIFE” DEI BAMBINI AFFETTI DA TROMBOCITOPENIA IMMUNE CRONICA (ITP): ESPERIENZA MULTICENTRICA DELLA ASSOCIAZIONE ITALIANA DI EMATOLOGIA ED ONCOLOGIA PEDIATRICA (AIEOP) 72
Multi-parameter neurological study based on combined conventional and functional assessments in Gaucher disease patients (SENOPRO_GAUCHER Study) 70
Response of AIHA to high dose intravenous immunoglobulins in a patient with ovarian teratoma 69
Non-invasive ventilation for severe TRALI and myocardial stunning: Report and literature review 69
GIMEMA-AIEOP AIDA Protocol for the Treatment of newly diagnosed Acute Promyelocytic Leukemia (APL) in Children. 69
Alterazioni coagulative in soggetti di età <20 anni con disordini mieloproliferativi cronici (DMC) bcr/abl- 69
ITP-QoL questionnaire for children with immune thrombocytopenia: Italian version validation's 69
EFFICACIA E SICUREZZA DELL’IMPIEGO DEI PICC IN PAZIENTI PEDIATRICI AFFETTI DA LEUCEMIA ACUTA: ESPERIENZA MONOCENTRICA 69
Long-term efficacy and safety results of taliglucerase alfa up to 36 months in adult treatment-naïve patients with Gaucher disease 69
Identification of a novel recombinant allele in three unrelated Italian Gaucher patients: Implications for prognosis and genetic counseling 69
STUDIO OSSERVAZIONALE, PROSPETTICO, MULTICENTRICO SUL MONITORAGGIO DELLA TERAPIA CON FERRO ORALE NELLA ANEMIA SIDEROPENICA INFANTILE 68
Terapia della leucemia mieloide acuta del bambino resistente o in recidiva: risultati in 36 casi trattati con il protocollo MEC (Mitoxantrone, Etoposide e dosi intermedie di Ara-C). 68
Movement and mood disorder in two brothers with Gaucher disease 67
Porpora trombocitopenica idiomatica (PTI): terapia con alte dosi di desametasone nei bambini e negli adolescenti. [Idiopathic Thrombocytopenic Purpura: Therapy with high doses of desametasone in children and adolescents] 66
The proportion of different BCR-ABL1 transcript types in chronic myeloid leukemia. An international overview 66
Specific guidelines including multidisciplinary approach is critical of management of Langerhans Cell Histiocytosis in adults 66
Istiocitosi a cellule di Langherans dell’adulto. Manifestazioni orali 65
Alte dosi di ARA-C + Idarubicina nel trattamento della leucemia linfoide acuta in fase avanzata 64
Langerhans Cell Histiocytosis With Orbital Involvement: Our Experience 64
Long-term follow-up of Philadelphia chromosome-positive (Ph+) chronic myeloid leukaemia (CML) in children and adolescents managed at a single institution over a 20-year period 64
Intermittent Imatinib mesylate in children with chronic myeloid leukemia: results and outcome 64
Bone metabolism, growth rate and pubertal development in children with chronic myeloid leukemia treated with imatinib during puberty. 63
Pivotal trial with plant-cell-expressed recombinant glucocerebrosidase, taliglucerase alfa, a novel enzyme replacement therapy for Gaucher disease. 63
Therapeutic strategies for postremission treatment in childhood acute myeloid leukemia (AML). The AIEOP experience 1987-1991. 62
Management of Chronic Myeloid Leukemia in children and adolescents according to local guidelines the Italian experience 62
A single high dose of idarubicin combined with high-dose ABA-C (MSKCC ALL-3 protocol) in adult and pediatric patients with acute lymphoblastic leukemia. Experience at the University La Sapienza of Rome. 62
Vindesine in the treatment of refractory hematologic malignancies: A phase II study 61
Early diagnosis of Gaucher disease in pediatric patients: Proposal for a diagnostic algorithm 61
Evidence for a founder effect of the MPL-S505N mutation in eight Italian pedigrees with hereditary thrombocythemia 61
Vindesine in the treatment of refractory hematologic malignancies: A phase II study 60
Early Response Does Not Impact on the Long-Term Outcome of Children and Adolescents with Chronic Myeloid Leukemia Treated with High-Dose Imatinib. The Italian Experience. 59
Platelet size for distinguishing between inherited thrombocytopenias and immune thrombocytopenia: A multicentric, real life study 59
A single high dose of idarubicin combined with high-dose ARA-C (MSKCC ALL-3 protocol) in adult and pediatric patients with acute lymphoblastic leukemia. Experience at the University "La Sapienza" of Rome. 59
Platelet function and coagulation abnormalities in type 1 Gaucher disease patients: effects of enzyme replacement therapy (ERT). 59
Acute lymphoblastic leukemia (ALL) primary refractory or in first relapse: results in children and adults over a 20-year period. 58
Juvenile chronic myeloid leukemia (CML): A single center 20-year experience. 58
Mast cell disorders, melanoma and pancreatic carcinoma: from a clinical observation to a brief review of the literature 58
Successful management of a chronic refractory leg ulcer in an adolescent with sickle cell anemia 58
Myelodysplasia as assessed by multiparameter flow cytometry refines prognostic stratification provided by genotypic risk in systemic mastocytosis 58
MRP4 Expression and Platelet Activation in Children and Adolescents with Different Subtypes of Primary Thrombocythemia 58
Difference in outcome of adolescents with acute lymphoblastic leukemia (ALL) enrolled in pediatric (AIEOP) and adult (GIMEMA) protocols 57
Idarubicin plus Cytosine-Arabinoside (ALL R-87 Protocol) in advanced acute lymphoblastic leukemia: the GIMEMA/AIEOP experience. 57
Multiple granuloma faciale: A clinical finding from a dermoscopic point a view 57
The Italian Mastocytosis Registry: a 6-year experience of a hospital-based registry. 57
Indagine immunoenzimatica su citocentrifugati di sangue periferico per la valutazione della terapia con IFN e/o DCF nella Hairy Cell Leukemia 56
Treatment of primary refractory and relapsed acute lymphoblastic leukaemia in children and adults: the GIMEMA/AIEOP experience. 56
HIGH DOSE INTRAVENOUS GAMMAGLOBULIN (HDIVG): THERAPY OF REFRACTORY ITP IN ADULTS AND CHILDREN 55
RADIATION TREATMENT OF TESTICULAR RELAPSE IN ACUTE LYMPHOBLASTIC-LEUKEMIA 55
The mutant JAK2(V617F) allele burden in children with essential thrombocythemia 55
Totale 9.613
Salva come PNG Salva come JPEG
Categoria #
all - tutte 54.786
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 54.786
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.360 0 0 0 0 0 0 280 280 253 262 182 103
2020/20211.070 107 86 40 132 107 60 40 146 100 74 124 54
2021/20223.453 73 189 270 234 522 90 56 277 245 304 449 744
2022/20234.283 1.027 596 188 482 392 637 77 229 381 60 135 79
2023/20242.334 165 267 124 148 147 165 106 346 27 315 228 296
2024/20252.273 305 617 254 194 403 386 114 0 0 0 0 0
Totale 18.986